Projects per year
Search results
-
Active
-
An Open-label, Multicenter Trial of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of M1774 in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)
Singh, M., Abdelrahim, M., Heyne, K., Niravath, P. A. & Zhang, J.
7/25/22 → …
Project: Clinical Trial
-
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
Zaid, T., Alaniz, A., Coffey, D., Singh, M. & Suri, A.
6/22/22 → …
Project: Clinical Trial
-
A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
5/2/22 → …
Project: Clinical Trial
-
-
Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma-CoImmune CMN-001-1
Satkunasivam, R., Singh, M. & Zhang, J.
8/26/21 → …
Project: Clinical Trial
-
GOG-3044 LAE002INT2001
Kamat, A. A., Alaniz, A., Singh, M., Suri, A. & Zaid, T.
4/16/21 → …
Project: Clinical Trial
-
An Open-Label Randomized Active-Controlled Phase II Clinical Study to Assess the Efficacy and Safety of Afuresertib Plus Paclitaxel Versus Paclitaxel in Patients with Platinum-ResistantOvarian Cancer
Kamat, A. A., Alaniz, A., Darcourt, J., Singh, M., Suri, A. & Zaid, T.
3/15/21 → 3/14/46
Project: Non Profit
-
Sample and Data Collection for Houston Methodist Cancer Center Research
Chang, J. C., Bernicker, E. H., Darcourt, J., Heyne, K., Niravath, P. A. & Singh, M.
4/9/20 → …
Project: Clinical Trial
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy
Niravath, P. A., Antosh, D., Chang, J. C., Singh, M. & Zaid, T.
5/9/19 → …
Project: Clinical Trial
-
A phase III, multicenter, randomized, study of atezolizumab/placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly-diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal cancer
Kamat, A. A., Alaniz, A., Bernicker, E. H., Darcourt, J., Heyne, K., Singh, M., Suri, A. & Zaid, T.
3/13/18 → 3/12/43
Project: Non Profit
-
EAY131 - Molecular Analysis for Therapy Choice (MATCH)
Bernicker, E. H., Chang, J. C., Darcourt, J., Heyne, K., Kamat, A. A., Pingali, S. R. & Singh, M.
9/20/16 → 9/20/41
Project: Federal Funding Agencies
-
Metastatic Stem Cells-ROLE OF CANCER STEM CELLS IN BREAST CANCER RECURRENCE AND METASTASIS
Chang, J. C., Niravath, P. A. & Singh, M.
3/20/14 → …
Project: Clinical Trial
-
Stem Cell: Biomarkers Including Putative Stem Cells Markers in Human Breast Cancers
Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Templeton, S.
3/20/14 → …
Project: Clinical Trial
-
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab (IND #134427) Versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab in P
Kamat, A. A., Darcourt, J., Singh, M., Suri, A. & Zaid, T.
3/1/14 → 2/28/39
Project: Non Profit
-
A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination withIntravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVACancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer.
Zaid, T., Butler, E. B., Darcourt, J., Farach, A. M., Kamat, A. A., Shkedy, C., Singh, M. & Suri, A.
3/1/14 → 2/28/39
Project: Non Profit
-
Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study:A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with orwithout Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients withDefici
Abdelrahim, M., Bernicker, E. H., Darcourt, J., Heyne, K. & Singh, M.
3/1/14 → 2/28/39
Project: Non Profit
-
PHASE III RANDOMIZED STUDY OF SORAFENIB PLUS DOXORUBICIN VERSUS SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Bernicker, E. H., Darcourt, J. & Singh, M.
8/13/13 → 8/12/38
Project: Non Profit
-
A Phase II/III Trial of Neoadjuvant FOLFOX w/ Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection w/ Total Mesorectal Excisio
Bernicker, E. H., Darcourt, J. & Singh, M.
6/11/13 → 6/10/38
Project: Non Profit
-
A Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D in premenopausal Women at High Risk for Breast Cancer, Phase IIB
6/29/12 → 3/22/37
Project: Federal Funding Agencies
-